The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the available information, a cause for the reported atrial perforation could not be determined.The reported patient effect of atrial perforation is listed in the mitraclip system instructions for use, and is a known possible complication associated with mitraclip procedures.The reported additional therapy/non-surgical treatment was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
|
This is filed to report atrial perforation.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (fmr) with a grade of 4.Noted a very small valve area less than 3 and a balloon pump was used to help flow.There was a high mean gradient of 10 and a max gradient of 20.Ultimately it was decided not to implant the clip so it was removed still attached to the cds.The mean pressure gradient returned to baseline.However, after the steerable guide catheter (sgc) was removed, a significant left atrial pressure was observed.To alleviate the left atrial pressure burden, the physician decided to implant an atrial septal defect (asd) device, but in order to maintain the shunt, the physician removed the polyester inserts from the asd device to maintain the asd.The physician decided to implant an asd closure device.The closure device was implanted successfully and transesophageal echography demonstrated significant intra-device shunting.No clips were implanted and mr remained grade 4.There were no reported adverse patient sequela and there was no reported clinically significant delay in the procedure.No additional information was provided.
|